Ephrin receptor 3D structures

3kka - hEPHR A1 SAM+ hEPH A2 SAM – human

3hil - hEPHR A1 SAM

2k1l, 2k1k - hEPHR A1 transmembrane domain – NMR

1x5a - hEPHR A1 fn3 domain – NMR<BR

3hpn, 3c8x - hEPHR A2 LBD

2x10, 3fl7 - hEPHR A2 ectodomain

2k9y, 2e8n - hEPHR A2 transmembrane domain – NMR

1mqb, 4p2k, 4pdo, 4trl, 5ek7, 5i9u - hEPHR A2 kinase domain

7kja - hEPHR A2 kinase+SAM domains

7kjb, 7kjc - hEPHR A2 kinase+SAM domains (mutant)

3mx0, 2x11 - hEPHR A2 ectodomain + ephrin A5

3hei, 3czu - hEPHR A2 LBD + ephrin A1

3mbw - hEPHR A2 LBD + carbohydrate-recognition domain + ephrin A1

6njz, 6nk0, 6nk1, 6nk2, 6nkp, 6b9l - hEPHR A2 LBD + peptide

6rw2 - hEPHR A2 LBD + bicycle toxin

7b7n, 7cze, 7czf - hEPHR A2 LBD + herpesvirus glycoproteins

2kso - hEPHR A2 SAM fragment residues 945-969 + SHIP2

5nz9 - hEPHR A2 SAM fragment - NMR

6f7m, 6f7n - hEPHR A2 SAM fragment (mutant) - NMR

5i9v, 5i9w, 5njz, 5nk0, 5nk1, 5nk2, 5nk3, 5nk4, 5nk5, 5nk6, 5nk7, 5nk8, 5nk9, 5nka, 5nkb, 5nkc, 5nkd, 5nke, 5nkf, 5nkg, 5nkh, 5nki, 6hes, 6het, 6heu, 6hev, 6hew, 6hex, 6hey, 6q7b, 6q7c, 6q7d, 6q7e, 6q7f, 6q7g, 8bin, 8bio, 8bk0 - hEPHR A2 kinase domain + inhibitor

6fnf, 6fng, 6fnh – hEPHR A2 kinase domain + pyrimidine derivative

5i9x, 5i9y, 5i9z, 5ia0, 5ia1, 5ia2, 5ia3, 5ia4, 5ia5 - hEPHR A2 kinase domain + kinase drug

2qo2, 2qob, 2gsf - hEPHR A3 kinase domain

2qok, 2qol, 2qon, 2qoo, 2qod, 2qof, 2qoi - hEPHR A3 kinase domain (mutant)

3fxx, 3fy2 – hEPHR A3 kinase domain + peptide substrate

2qoq, 2qo7, 2qo9, 2qoc - hEPHR A3 kinase domain + AMP-PNP

3dzq, 4gk2, 4gk3, 4gk4, 4p5q, 4p5z, 4p4c, 4twn, 4two, 6in0 - hEPHR A3 kinase domain + inhibitor

4g2f - hEPHR A3 kinase domain (mutant) + inhibitor

4l0p - hEPHR A3 LBD + Ephrin-A5

2wo1, 3ckh - hEPHR A4 LBD

4bk4, 4m4p - hEPHR A4 ectodomain

2lw8 - hEPHR A4 LBD – NMR

7ofv - hEPHR A4 LBD + polypeptide inhibitor

6fnl – hEPHR A4 kinase domain

2hel – mEPHR A4 membrane and kinase domains – mouse

2y6m – mEPHR A4 kinase domain

2wo3 - hEPHR A4 LBD + ephrin A2 receptor-binding domain

4w4z, 4w50, 5jr2 - hEPHR A4 LBD (mutant) + peptide

2wo2, 3gxu - hEPHR A4 LBD + ephrin B2 receptor-binding domain

4bk5, 4bka, 4m4r - hEPHR A4 ectodomain + ephrin A5 LBD

4bkf - hEPHR A4 ectodomain + ephrin B3 LBD

6fnm – hEPHR A4 kinase domain + dasatinib

6fni, 6fnj, 6fnk – hEPHR A4 kinase domain + pyrimidine derivative

2xyu – mEPHR A4 kinase domain + inhibitor

2y6o – mEPHR A4 kinase domain + cancer drug

2r2p - hEPHR A5 kinase domain

4et7 – hEPHR A5 LBD (mutant)

1shx - mEPHR A5

5zrz – mEPHR SAM domain + SAMD5

3nru – hEPHR A7 LBD

3h8m – hEPHR A7 SAM

2rei - hEPHR A7 kinase domain

7eec, 7eed, 7eef - hEPHR A7 kinase domain (mutant)

3dko – hEPHR A7 kinase domain + inhibitor

3kul - hEPHR A8 kinase domain

1x5l – hEPHR A8 fn3 domain – NMR

1ucv - hEPHR A8 SAM – NMR

2eao – hEPHR B1 SAM – NMR

2djs - hEPHR B1 fn3 domain – NMR

3zfx - hEPHR B1 kinase domain residues 602-896

5mja - hEPHR B1 kinase domain + inhibitor

5mjb - hEPHR B1 kinase domain (mutant) + inhibitor

6umw - hEPHR B1 kinase domain + antibiotics

7kpl - hEPHR B1 172-450

7kpm - hEPHR B1 172-450 + ADP

3etp – hEPHR B2

1b4f - hEPHR B2 SAM

1f0m – mEPHR B2 SAM

1iko - mEPHR B2 ectodomain

2i85 - hEPHR B2 ectodomain

3zfm - hEPHR B2 kinase domain

1sgg - mEPHR B2 SAM – chicken - NMR

2vsk, 2vsm – hEPHR B2 + Viral Hemagglutinin-neuraminidase

2qbx – hEPHR B2 + peptide agonist

2hen - hEPHR B2 kinase domain + ADP

1shw - mEPHR B2 LBD + ephrin A5

1kgy - mEPHR B2 LBD + ephrin B2 extracellular domain

3p1i – hEPHR B3 LBD

3zfy - hEPHR B3 kinase domain

5l6o, 5l6p - hEPHR B3 kinase domain (mutant) + inhibitor

2qkq – hEPHR B4 SAM

2e7h – hEPHR B4 fn3 domain - NMR

2x9f, 2vwy - hEPHR B4 kinase domain (mutant)

2vwx, 2vwz, 2vx0, 2vx1, 2vwu, 2vwv, 2vww, 4aw5 – hEPHR B4 kinase domain + inhibitor

3zew - hEPHR B4 + staurosporine

2xvd, 2yn8, 4bb4 - hEPHR B4 kinase domain (mutant) + inhibitor

2hle, 2bba - hEPHR B4 LBD + ephrin B2

7k7j - hEPHR B6 ectodomain